These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28076753)

  • 1. CD25 targeted therapy of chemotherapy resistant leukemic stem cells using DR5 specific TRAIL peptide.
    Madhumathi J; Sridevi S; Verma RS
    Stem Cell Res; 2017 Mar; 19():65-75. PubMed ID: 28076753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel TNF-related Apoptotic-inducing Ligand-based Immunotoxin for Therapeutic Targeting of CD25 Positive Leukemia.
    Madhumathi J; Sridevi S; Verma RS
    Target Oncol; 2016 Aug; 11(4):535-47. PubMed ID: 26984209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin augments therapeutic efficacy of TRAIL-based immunotoxins in leukemia.
    Surapally S; Jayaprakasam M; Verma RS
    Pharmacol Rep; 2020 Aug; 72(4):1032-1046. PubMed ID: 32141025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding of tolerance in TRAIL-induced apoptosis and cancelation of its machinery by α-mangostin, a xanthone derivative.
    Kumazaki M; Shinohara H; Taniguchi K; Ueda H; Nishi M; Ryo A; Akao Y
    Oncotarget; 2015 Sep; 6(28):25828-42. PubMed ID: 26304927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2.
    Chamuleau ME; Ossenkoppele GJ; van Rhenen A; van Dreunen L; Jirka SM; Zevenbergen A; Schuurhuis GJ; van de Loosdrecht AA
    Leuk Res; 2011 Jun; 35(6):741-9. PubMed ID: 21281967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL).
    Zauli G; Rimondi E; Celeghini C; Milani D; Secchiero P
    J Cell Physiol; 2010 Feb; 222(2):357-64. PubMed ID: 19877156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified DT-IL2 fusion toxin targeting uniquely IL2Ralpha expressing leukemia cell lines - Construction and characterization.
    Potala S; Verma RS
    J Biotechnol; 2010 Jul; 148(2-3):147-55. PubMed ID: 20580754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piceatannol enhances TRAIL-induced apoptosis in human leukemia THP-1 cells through Sp1- and ERK-dependent DR5 up-regulation.
    Kang CH; Moon DO; Choi YH; Choi IW; Moon SK; Kim WJ; Kim GY
    Toxicol In Vitro; 2011 Apr; 25(3):605-12. PubMed ID: 21167276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
    Yasuda T; Yoshida T; Goda AE; Horinaka M; Yano K; Shiraishi T; Wakada M; Mizutani Y; Miki T; Sakai T
    Mol Cancer Res; 2008 Dec; 6(12):1852-60. PubMed ID: 19074830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells.
    Jo EB; Lee YS; Lee H; Park JB; Park H; Choi YL; Hong D; Kim SJ
    BMC Cancer; 2019 May; 19(1):496. PubMed ID: 31126284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of TRAIL and its receptor DR5 and their significance in acute leukemia cells.
    Chen SM; Sun H; Liu YF; Ma J; Zhang QT; Zhu J; Li T
    Genet Mol Res; 2015 Dec; 14(4):18562-8. PubMed ID: 26782504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells.
    Shiraishi T; Yoshida T; Nakata S; Horinaka M; Wakada M; Mizutani Y; Miki T; Sakai T
    Cancer Res; 2005 Jul; 65(14):6364-70. PubMed ID: 16024639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive oxygen species contribute to TRAIL receptors upregulation; the mechanism for PH II-7 augmenting TRAIL induced apoptosis in leukemia cells.
    Peng H; Yuan X; Luo S; Li F; Wei X; Ye Z; Xiong D
    Eur J Pharmacol; 2015 Jan; 746():344-52. PubMed ID: 25446561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRAIL-induced apoptosis of HL60 leukemia cells: two distinct phenotypes of acquired TRAIL resistance that are accompanied with resistance to TNFalpha but not to idarubicin and cytarabine.
    Klener P; Leahomschi S; Molinsky J; Simonova T; Necas E; Gasova Z; Cermak J; Dolezalova L; Andera L; Zivny J
    Blood Cells Mol Dis; 2009; 42(1):77-84. PubMed ID: 19038561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ionizing radiation sensitizes leukemic MOLT-4 cells to TRAIL-induced apoptosis.
    Rezácová M; Vávrová J; Vokurková D
    Acta Medica (Hradec Kralove); 2008; 51(2):101-5. PubMed ID: 18998361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations Enhancing Selectivity of Antitumor Cytokine TRAIL to DR5 Receptor Increase Its Cytotoxicity against Tumor Cells.
    Gasparian ME; Bychkov ML; Yagolovich AV; Dolgikh DA; Kirpichnikov MP
    Biochemistry (Mosc); 2015 Aug; 80(8):1080-91. PubMed ID: 26547077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pyrrolo-1,5-benzoxazepine, PBOX-15, enhances TRAIL‑induced apoptosis by upregulation of DR5 and downregulation of core cell survival proteins in acute lymphoblastic leukaemia cells.
    Nathwani SM; Greene LM; Butini S; Campiani G; Williams DC; Samali A; Szegezdi E; Zisterer DM
    Int J Oncol; 2016 Jul; 49(1):74-88. PubMed ID: 27176505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells.
    Kauntz H; Bousserouel S; Gossé F; Raul F
    Apoptosis; 2012 Aug; 17(8):797-809. PubMed ID: 22555452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells.
    Fujiwara J; Sowa Y; Horinaka M; Koyama M; Wakada M; Miki T; Sakai T
    Int J Oncol; 2012 May; 40(5):1483-91. PubMed ID: 22328338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCR-ABL regulates death receptor expression for TNF-related apoptosis-inducing ligand (TRAIL) in Philadelphia chromosome-positive leukemia.
    Kuroda I; Inukai T; Zhang X; Kikuchi J; Furukawa Y; Nemoto A; Akahane K; Hirose K; Honna-Oshiro H; Goi K; Kagami K; Yagita H; Tauchi T; Maeda Y; Sugita K
    Oncogene; 2013 Mar; 32(13):1670-81. PubMed ID: 22665066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.